ID26083A - Paroksetina 10-kamforsulfonat untuk pengobatan gangguan cns - Google Patents
Paroksetina 10-kamforsulfonat untuk pengobatan gangguan cnsInfo
- Publication number
- ID26083A ID26083A IDW20002168A ID20002168A ID26083A ID 26083 A ID26083 A ID 26083A ID W20002168 A IDW20002168 A ID W20002168A ID 20002168 A ID20002168 A ID 20002168A ID 26083 A ID26083 A ID 26083A
- Authority
- ID
- Indonesia
- Prior art keywords
- paroxoxine
- kamforsulfonate
- cns
- interference
- treatment
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9808896.6A GB9808896D0 (en) | 1998-04-25 | 1998-04-25 | Novel compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID26083A true ID26083A (id) | 2000-11-23 |
Family
ID=10831008
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDW20002168A ID26083A (id) | 1998-04-25 | 1999-04-23 | Paroksetina 10-kamforsulfonat untuk pengobatan gangguan cns |
| IDW20002169A ID26654A (id) | 1998-04-25 | 1999-04-23 | Paroksetin askorbat |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDW20002169A ID26654A (id) | 1998-04-25 | 1999-04-23 | Paroksetin askorbat |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1089995A1 (xx) |
| JP (1) | JP2002513019A (xx) |
| KR (1) | KR20010042977A (xx) |
| CN (1) | CN1297448A (xx) |
| AP (1) | AP2000001963A0 (xx) |
| AU (1) | AU3618499A (xx) |
| BG (1) | BG104940A (xx) |
| BR (1) | BR9909868A (xx) |
| CA (1) | CA2330055A1 (xx) |
| EA (1) | EA200001104A1 (xx) |
| GB (1) | GB9808896D0 (xx) |
| HU (1) | HUP0102116A3 (xx) |
| ID (2) | ID26083A (xx) |
| IL (1) | IL139081A0 (xx) |
| NO (1) | NO20005352L (xx) |
| PL (1) | PL343677A1 (xx) |
| SK (1) | SK15912000A3 (xx) |
| TR (1) | TR200003084T2 (xx) |
| WO (1) | WO1999055698A1 (xx) |
| ZA (1) | ZA200005912B (xx) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0003232D0 (en) * | 2000-02-11 | 2000-04-05 | Smithkline Beecham Plc | Novel composition |
| IL159280A0 (en) * | 2001-06-14 | 2004-06-01 | Teva Pharma | A process for preparing paroxetine hcl which limits formation of pink colored compounds |
| EP2272501B1 (en) * | 2002-01-09 | 2013-03-20 | Emisphere Technologies, Inc. | Polymorphs of sodium 4-((4-chloro-2-hydroxybenzoyl) amino) butanoate |
| CN110607554B (zh) * | 2018-10-30 | 2024-03-22 | 中国科学院化学研究所 | 一种制备药物或药物中间体单晶或无定型物的方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1422263A (en) * | 1973-01-30 | 1976-01-21 | Ferrosan As | 4-phenyl-piperidine compounds |
| DE3688827T2 (de) * | 1985-10-25 | 1994-03-31 | Beecham Group Plc | Piperidinderivat, seine Herstellung und seine Verwendung als Arzneimittel. |
| US5276042A (en) * | 1993-04-16 | 1994-01-04 | Crenshaw Roger T | Treatment of premature ejaculation |
| ES2117557B1 (es) * | 1996-02-29 | 1999-07-01 | Ferrer Int | Nuevo procedimiento de obtencion de (-)-trans -n-p-fluorobenzoilmetil-4-(p-fluorofenil)-3- ((3,4-(metilendioxi)fenoxi ) metil)-piperidina. |
-
1998
- 1998-04-25 GB GBGB9808896.6A patent/GB9808896D0/en not_active Ceased
-
1999
- 1999-04-23 JP JP2000545858A patent/JP2002513019A/ja active Pending
- 1999-04-23 PL PL99343677A patent/PL343677A1/xx not_active Application Discontinuation
- 1999-04-23 BR BR9909868-7A patent/BR9909868A/pt not_active Application Discontinuation
- 1999-04-23 AP APAP/P/2000/001963A patent/AP2000001963A0/en unknown
- 1999-04-23 IL IL13908199A patent/IL139081A0/xx unknown
- 1999-04-23 EA EA200001104A patent/EA200001104A1/ru unknown
- 1999-04-23 CN CN99805160A patent/CN1297448A/zh active Pending
- 1999-04-23 ID IDW20002168A patent/ID26083A/id unknown
- 1999-04-23 ID IDW20002169A patent/ID26654A/id unknown
- 1999-04-23 SK SK1591-2000A patent/SK15912000A3/sk unknown
- 1999-04-23 EP EP99918151A patent/EP1089995A1/en not_active Withdrawn
- 1999-04-23 KR KR1020007011809A patent/KR20010042977A/ko not_active Application Discontinuation
- 1999-04-23 CA CA002330055A patent/CA2330055A1/en not_active Abandoned
- 1999-04-23 AU AU36184/99A patent/AU3618499A/en not_active Abandoned
- 1999-04-23 WO PCT/GB1999/001244 patent/WO1999055698A1/en not_active Application Discontinuation
- 1999-04-23 HU HU0102116A patent/HUP0102116A3/hu unknown
- 1999-04-23 TR TR2000/03084T patent/TR200003084T2/xx unknown
-
2000
- 2000-10-23 ZA ZA200005912A patent/ZA200005912B/en unknown
- 2000-10-24 NO NO20005352A patent/NO20005352L/no not_active Application Discontinuation
- 2000-11-13 BG BG104940A patent/BG104940A/bg unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ID26654A (id) | 2001-01-25 |
| TR200003084T2 (tr) | 2001-02-21 |
| HUP0102116A2 (hu) | 2002-05-29 |
| SK15912000A3 (sk) | 2001-04-09 |
| KR20010042977A (ko) | 2001-05-25 |
| BR9909868A (pt) | 2000-12-19 |
| BG104940A (bg) | 2001-09-28 |
| EP1089995A1 (en) | 2001-04-11 |
| NO20005352D0 (no) | 2000-10-24 |
| IL139081A0 (en) | 2001-11-25 |
| WO1999055698A1 (en) | 1999-11-04 |
| GB9808896D0 (en) | 1998-06-24 |
| JP2002513019A (ja) | 2002-05-08 |
| CN1297448A (zh) | 2001-05-30 |
| EA200001104A1 (ru) | 2001-04-23 |
| ZA200005912B (en) | 2001-12-19 |
| NO20005352L (no) | 2000-10-24 |
| AU3618499A (en) | 1999-11-16 |
| PL343677A1 (en) | 2001-08-27 |
| HUP0102116A3 (en) | 2002-12-28 |
| AP2000001963A0 (en) | 2000-12-31 |
| CA2330055A1 (en) | 1999-11-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20012995D0 (no) | Forbindelse nyttige for behandling av inflammatoriske sykdommer | |
| ID30062A (id) | Alanog-analog benzopiran tersubstitusi untuk pengobatan radang | |
| ID24638A (id) | Senyawa-senyawa anti aritmia bispidina | |
| ID27191A (id) | Metode untuk pengobatan insomnia | |
| NO20003065D0 (no) | Kombinasjon for effektiv behandling av impotens | |
| ID26990A (id) | Metode pembuatan dimetilnaftalena | |
| ID25901A (id) | Proses pembuatan 4-aminometil-pirolidin-3-on terlindung | |
| ID27214A (id) | Triazolopiridina untuk pengobatan gangguan trombosis | |
| ID17723A (id) | Senyawa untuk pengobatan | |
| IS4789A (is) | Meðferðarefnasambönd | |
| ID28032A (id) | TRISIKLIK PIPERIDIN-Δ3-SEBAGAI ANTAGONIS-α2 | |
| NO20003211D0 (no) | Triazinforbindelser for behandling av CNS forstyrrelser | |
| ID26083A (id) | Paroksetina 10-kamforsulfonat untuk pengobatan gangguan cns | |
| NO20003481D0 (no) | FremgangsmÕte for behandling av COPD | |
| NO20012099D0 (no) | Fremgangsmåte for fremstilling av 4-arylpiperidin-3- carbinoler og beslektede forbindelser | |
| ID21920A (id) | 4-6-fluoro-(1h)-indol-3-il-1,2,3,6-tetrahidropirin tersubstitusi untuk pengobatan gangguan cns | |
| PT1175417E (pt) | Compostos substituidos de benzolactamas | |
| NO20006383L (no) | Fremgangsmåte for behandling | |
| PT1088010E (pt) | Producao de poliolefinas | |
| IL126681A0 (en) | Treatment of trauma-related conditions | |
| IL138843A0 (en) | Improved process for the manufacture of n- (1-cyanoalkyl) -2-phenoxypropionamide derivatives | |
| FI981803A0 (fi) | Menetelmä saostumien muodostumisen estämiseksi | |
| NO20012301D0 (no) | Ny fremgangsmåte for behandling | |
| NO20006382D0 (no) | Fremgangsmåte for behandling av organofosfatforgiftning | |
| NO20005351D0 (no) | Paroksetin 10-kamfersulfonat for behandling av CNS lidelser |